| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,203,060 | 1,373,798 | 1,626,121 | 1,660,242 | | Cost of Revenue | 378,485 | 3,426,086 | 444,647 | 447,742 | | | Gross Profit | 824,575 | (2,052,288) | 1,181,474 | 1,212,500 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 544,884 | (2,392,293) | 823,703 | 863,402 | | Non Recurring | 212 | 52,112 | (10,400) | (10,119) | | Others | 222,521 | 213,656 | 214,593 | 209,250 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 56,958 | 74,237 | 153,578 | 149,967 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 543 | (957) | 296 | | Earnings Before Interest And Taxes | 56,958 | 74,780 | 152,621 | 150,263 | | Interest Expense | 38,807 | 41,602 | 40,639 | 37,588 | | Income Before Tax | 18,151 | 33,178 | 111,982 | 112,675 | | Income Tax Expense | 11,313 | 22,532 | 41,774 | 49,730 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,838 | 10,646 | 70,208 | 62,945 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,838 | 10,646 | 70,208 | 62,945 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,838 | $10,646 | $70,208 | $62,945 |
|
0.45% Nasdaq 
0.20%
Income Statement
